Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
How is your sleep now
Compounding pharmacies customize peptide preparations to individual prescriptions
Disclosure of interest: Anastasios Mavridis: Nothing to Disclose, Adam Viktorisson: Nothing to Disclose, Bjrn Eliasson: Nothing to Disclose, Mia von Euler: Nothing to Disclose, Katharina S Sunnerhagen: Nothing to Disclose Poster Session II - RISK FACTORS - PRIMARY AND SECONDAR PREVENTION 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.04 - STROKE COMPLICATIONS P999 - ESOC25-160 PREDICTORS OF 90-DAY OUTCOMES AND HEMORRHAGIC RISK AFTER ENDOVASCULAR THROMBECTOMY WITH STENT RELEASE IN PATIENTS WITH ACUTE CAROTID ARTERY ATHEROSCLEROTIC ISCHEMIC STROKE Gaia Mignani 1 , Marta Del Chicca 1 , Nicola Giannini 1 , Marco Baldini 1 , Roberto D'agliano 1 , Alessandro Grigolini 2 , Giacomo Petrucci 2 , Filippo Baldacci 1 , Mirco Cosottini 2 1 Neurological Clinic, University of Pisa, Pisa, Italy, 2 Neuroradiology Unit, University of Pisa, Pisa, Italy Background and Aims: To investigate clinical and procedural factors associated with the 90-day modified Rankin Scale (mRS) and symptomatic intracranial hemorrhage (sICH) at 6 and 12 hours after endovascular thrombectomy (EVT) with carotid stent release
the 20 mg vial, at ~80 documented doses, is built for a longer one
US$ 29.23
US$ 22.56
US$ 26.84
US$ 25.04
US$ 22.35
US$ 27.56
US$ 22.59
US$ 26.18
US$ 27.65
US$ 27.35
US$ 24.19
US$ 22.68
US$ 28.56
US$ 20.86